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SNARE-mediated synaptic exocytosis is orches-
trated by facilitatory and inhibitory mechanisms.
Genetic ablations of Complexins, a family of SNARE-
complex-binding proteins, in mice and Drosophila
cause apparently opposite effects on neurotrans-
mitter release, leading to contradictory hypotheses
of Complexin function. Reconstitution experiments
withdifferent fusionassaysandComplexinsalsoyield
conflicting results. We therefore performed cross-
species rescue experiments to compare the functions
of murine and Drosophila Complexins in both
mouse and fly synapses. We found that murine and
Drosophila Complexins employ conserved mecha-
nisms to regulate exocytosis despite their strikingly
different overall effects on neurotransmitter release.
Both Complexins contain distinct domains that facili-
tate or inhibit synaptic vesicle fusion, and the strength
of each facilitatory or inhibitory function differs signif-
icantly between murine and Drosophila Complexins.
Our results show that a relative shift in the balance
of facilitatory and inhibitory functions results in differ-
ential regulationofneurotransmitter releasebymurine
and Drosophila Complexins in vivo, reconciling
previous incompatible findings.
INTRODUCTION
SNARE (soluble N-ethylmaleimide-sensitive factor-attachment
protein receptor)-mediated synaptic vesicle exocytosis is tightly
controlled by a large number of regulatory proteins to ensure the
exquisite temporal and spatial precision of neurotransmitter
release at synapses (Brunger, 2005; Jahn and Scheller, 2006).Complexins constitute a family of small and highly charged
proteins that bind to the assembled SNARE complex (Ishizuka
et al., 1995; McMahon et al., 1995; Reim et al., 2005; Takahashi
et al., 1995). They generally contain a central a helix and an
accessory a helix in the middle portion of the protein, and the
N- and C-terminal sequences that are probably largely unstruc-
tured (Pabst et al., 2000). Complexins bind to the SNARE
complex with high affinity (Bowen et al., 2005; Li et al., 2007;
Pabst et al., 2002). The central a helix of Complexins interacts
with the SNARE motifs of Syntaxin-1 and Synaptobrevin-2 within
the SNARE complex in an antiparallel fashion (Bracher et al.,
2002; Chen et al., 2002). Complexins can also bind to the
target-SNAREs’ (Syntaxin-1 and SNAP-25) heterodimer with
a lower affinity (Guan et al., 2008; Weninger et al., 2008; Yoon
et al., 2008).
Biophysical and physiological studies have indicated diverse
functions for Complexins in vesicle fusion, some of which are
incompatible (Brose, 2008). Complexins have been shown to
inhibit SNARE-mediated cell fusion (Giraudo et al., 2006) and pro-
teoliposome fusion in bulk ensemble assay (Schaub et al., 2006),
and this inhibition is released by the Ca2+ sensor Synaptotagmin-
1 and Ca2+. Biochemically, Synaptotagmin-1 competes with
Complexins for the SNARE complex binding and displaces Com-
plexins from the SNARE complex in a Ca2+-dependent manner
(Tang et al., 2006). These studies suggest a fusion clamp model
for Complexin function, in which Complexins inhibit the transfer
of the force generated by the SNARE complex assembly onto
the fusing membranes and arrest synaptic vesicle fusion before
Ca2+ influx. Upon Ca2+ binding, Synaptotagmin-1 displaces
Complexins from the SNARE complex to release this inhibition
and triggers exocytosis (Giraudo et al., 2006; Maximov et al.,
2009; Schaub et al., 2006; Tang et al., 2006). However, Complex-
ins have also been shown to stimulate proteoliposome fusion in
both single-vesicle fusion assay (Yoon et al., 2008) and bulk
ensemble assay (Malsam et al., 2009), indicating a facilitatory
role. These in vitro results are further confounded by in vivo
genetic studies. Genetic knockout of Complexins in mice leadsNeuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc. 367
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multiple glutamatergic and GABAergic synapses in cultures
and in acute brain slices (Reim et al., 2001; Strenzke et al.,
2009; Xue et al., 2008b), and a decrease in Ca2+-triggered exocy-
tosis in adrenal chromaffin cells (Cai et al., 2008), supporting
a stimulatory function for Complexins. In contrast, genetic dele-
tion of Complexin in fruit fly Drosophila melanogaster greatly
enhances spontaneous release but decreases Ca2+-evoked
release (Huntwork and Littleton, 2007), favoring the fusion clamp
model. Moreover, knockdown of Complexins by RNA interfer-
ence in mass-cultured mouse cortical neurons decreases
evoked release and increases spontaneous release at glutama-
tergic synapses (Maximov et al., 2009). To explain the discrep-
ancy between this result and those obtained previously from
Complexin knockout mice, the authors (Maximov et al., 2009)
suggest that this is due to the different preparations used (autap-
tic cultures for knockout studies [Reim et al., 2001; Xue et al.,
2008b] versus mass cultures for knockdown study [Maximov
et al., 2009]), disavowing the fact that the knockout studies also
employed mass cultures and acute brain slices (Xue et al.,
2008b), and found similar results to those obtained from autaptic
cultures. Hence, many studies seem at odds with each other and
the precise in vivo role of Complexins in exocytosis is still unclear.
An in vivo structure-function analysis of murine Complexin I
(CplxI) in Complexin I/II double knockout mouse neurons indi-
cates that the SNARE complex binding is essential for CplxI
function, and that the N terminus of CplxI facilitates release,
whereas an accessory a helix between the N terminus and the
central a helix inhibits release (Xue et al., 2007). A biophysical
study reveals that CplxI inhibits SNARE complex formation, but
strongly stimulates membrane fusion after the assembly of the
SNARE complex in vitro (Yoon et al., 2008). These studies indi-
cate that Complexins play both facilitatory and inhibitory roles
in exocytosis, but they still do not explain why genetic deletions
of Complexins in two model organisms, mouse and fly, have
such different effects on neurotransmitter release. Furthermore,
the amino acid sequence homology is low between murine and
Drosophila Complexins except for the central a helix that is
essential for the binding to the SNARE complex, and part of
the N terminus (Figure S1 available online; Huntwork and Little-
ton, 2007; Reim et al., 2005). Thus, the dramatic difference in
loss-of-function phenotypes of Complexin-deficient mice and
flies leads to the conclusion that Complexin function must differ
between mice and flies.
To test whether the functions of murine and Drosophila Com-
plexins are conserved in synaptic vesicle exocytosis, and to gain
insight into their functional and structural differences, it is essen-
tial to compare murine and Drosophila Complexins in the same
experimental in vivo systems. A detailed structure-function
analysis is also necessary because a complete removal of
Complexins is unlikely to reveal all aspects of their function
(Xue et al., 2007). We therefore undertook a systematic cross-
species rescue approach to compare the functions of murine
and Drosophila Complexins at both mouse and fly synapses.
We find that both murine and Drosophila Complexins contain
distinct functional domains and play dual roles in neurotrans-
mitter release. They facilitate and inhibit release via similar
domains, but the facilitatory or inhibitory strength of a given368 Neuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc.domain varies between murine and Drosophila Complexins.
Thus, both murine and Drosophila Complexins utilize conserved
mechanisms in release process, but the integration of facilitation
and inhibition differs substantially between them, leading to an
apparently opposite overall effect on exocytosis. Our results
reveal conserved functions of Complexins between species
and indicate that the interplay of dual functions orchestrates
neurotransmitter release.
RESULTS
Drosophila Cplx Arrests Neurotransmitter Release
in Cplx-TKO Mouse Neurons
Prior to examining Complexin function at mouse synapses, we
assessed Complexin protein localization by immunostaining
and confocal micrscopy. The antibodies against Drosophila
Complexin (dmCplx) or CplxI show some nonspecific labeling
in immunostaining of mouse neurons; we therefore generated
enhanced green fluorescent protein (EGFP)-tagged dmCplx
and CplxI. We transfected cultured hippocampal neurons with
EGFP-dmCplx and EGFP-CplxI, and immunolabeled the
neurons with antibodies against EGFP and a presynaptic
marker, vesicular glutamate transporter-1 (Vglut-1). EGFP-CplxI
is distributed diffusely in axonal processes and synapses (Fig-
ure 1A), consistent with previous subcellular localization studies
(McMahon et al., 1995; Reim et al., 2005). In contrast, EGFP-
dmCplx shows a punctate pattern along axons and is enriched
at presynaptic varicosities (Figure 1A). The synaptic localization
of EGFP-dmCplx is similar to the punctate distribution of murine
CplxIII and CplxIV, which is mediated by farnesylation of their C
termini (Reim et al., 2005; and see below). Nevertheless, both
EGFP-dmCplx and EGFP-CplxI are present at presynaptic
termini that are labeled by Vglut-1, indicating that both CplxI
and dmCplx reach synapses in mouse neurons (Figure 1A).
To study the effect of dmCplx in neurotransmitter release, we
used lentiviruses to express wild-type (WT) dmCplx and CplxI at
similar levels in cultured hippocampal neurons (Supplemental
Results and Figure S2). Autaptic Complexin I/II/III triple knockout
(Cplx-TKO) neurons were infected with lentiviruses expressing
CplxI or dmCplx together with EGFP, or with lentiviruses only ex-
pressing EGFP. In response to an action potential, the excitatory
postsynaptic current (EPSC) amplitude of Cplx-TKO neurons is
severely reduced, and this defect is fully rescued by the expres-
sion of CplxI (Figures 1B and 1D; Xue et al., 2007). Strikingly,
expression of dmCplx in Cplx-TKO neurons almost abolishes
the remaining evoked release (Figures 1B and 1D), showing
that CplxI and dmCplx affect synaptic transmission in opposite
ways in vivo. To directly assess the Ca2+-triggered release effi-
cacy, we determined the vesicular release probability (Pvr), the
fraction of the readily releasable vesicles released by one action
potential. We measured readily releasable vesicle pool (RRP) by
hypertonic sucrose solution (Rosenmund and Stevens, 1996)
and Pvr was calculated as the ratio of evoked EPSC charge
and RRP charge. Expression of CplxI fully rescues the
decreased Pvr of Cplx-TKO neurons (Figure 1F; Xue et al.,
2007), whereas dmCplx reduces the Pvr by more than 98%
compared to Cplx-TKO neurons (Figure 1F). The numbers of
fusion-competent vesicles in RRP are not significantly different
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expression of CplxI rescues the decreased miniature EPSC
(mEPSC) frequency ofCplx-TKO neurons, in contrast to dmCplx,
which suppresses the mEPSC frequency by more than 96% in
Cplx-TKO neurons (Figures 1C and 1G). The inhibitory effect of
dmCplx is not restricted to hippocampal glutamatergic autap-
ses, as it also inhibits release in striatal GABAergic autaptic
neurons (Figure S3) and in hippocampal mass-cultured neurons
(Figure S4). In summary, these data show that CplxI facilitates
both evoked and spontaneous release, and that dmCplx practi-
cally abolishes evoked and spontaneous release in mouse
neurons without affecting the number of fusion-competent vesi-
cles. Thus, these results are in agreement with the proposed
functions for murine and Drosophila Complexins based on
genetic loss-of-function studies (Huntwork and Littleton, 2007;
Xue et al., 2008b).
Overexpression of Murine CplxI and Drosophila Cplx
in WT Mouse Neurons
Expression of dmCplx inCplx-TKO hippocampal neurons blocks
both evoked and spontaneous release, whereas CplxI rescues
the reduced evoked and spontaneous release of Cplx-TKO
neurons (Figure 1). Previous studies showed that greater than
10-fold overexpression of CplxI by Semliki Forest viruses in
WT hippocampal neurons does not alter neurotransmitter
release, indicating that CplxI does not act as a fusion clamp
(Xue et al., 2007). If dmCplx functions as a fusion clamp, one
would predict that overexpression of dmCplx in WT neurons
should inhibit release. To test this hypothesis, we compared
WT neurons overexpressing EGFP with those overexpressing
dmCplx or CplxI together with EGFP (Figure 2). Consistent with
previous results, lentiviral overexpression of CplxI in WT neurons
does not significantly affect either evoked or spontaneous
release (Figures 2A–2K, p > 0.05 for all tested parameters). In
contrast, overexpression of dmCplx at levels similar to those of
CplxI (Supplemental Results and Figure S2) strongly suppresses
EPSC amplitude (Figures 2A and 2C) without affecting the RRP
size (Figure 2D). Consequently, the Pvr of evoked release is
drastically reduced in WT neurons overexpressing dmCplx
Figure 1. Murine CplxI Facilitates, whereas Drosophila Cplx Inhibits,
Neurotransmitter Release in Cplx-TKO Hippocampal Neurons
(A) In cultured hippocampal neurons, EGFP-CplxI and EGFP-dmCplx are
present at presynaptic termini labeled by a presynaptic marker, Vglut-1. White
arrowheads indicate the synaptic varicosities containing Vglut-1 and EGFP-
CplxI or EGFP-dmCplx. Scale bars: 2 mm.
(B) Representative traces of evoked EPSCs. The arrows represent stimula-
tions; artifacts and action potentials are blanked.
(C) Representative traces of mEPSCs.
(D–G) Summary data for Cplx-TKO and CplxI- or dmCplx-rescued Cplx-TKO
neurons. (D) Amplitude of EPSC evoked by single action potentials. Cplx-
TKO and CplxI-rescued neurons all showed evoked EPSCs, whereas 22 out
of 39 dmCplx-rescued neurons showed no detectable EPSCs. (E) Readily
releasable pool vesicle number (transient synaptic charge induced by hyper-
tonic sucrose solution divided by the mEPSC charge). (F) Vesicular release
probability (Pvr) of evoked release. (G) mEPSC frequency. Cplx-TKO and
CplxI-rescued neurons all showed mEPSCs, whereas 11 out of 38 dmCplx-
rescued neurons showed no detectable mEPSCs. Data are expressed as
mean ± SEM. *p < 0.01; **p < 0.001; ***p < 0.0001 compared to Cplx-TKO
neurons. The numbers of neurons analyzed are shown above the bars.Neuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc. 369
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of dmCplx alters the short-term synaptic plasticity of WT
neurons, from mild depression to strong facilitation during repet-
itive high-frequency stimulations (Figures 2B, 2F, and 2G). These
results indicate that WT neurons overexpressing dmCplx are
less sensitive to Ca2+. To test this, we measured evoked EPSC
amplitudes as a function of the external Ca2+ concentrations
and fitted the data with a standard Hill equation to obtain the
dissociation constant (Kd) as a measure of the apparent Ca
2+
sensitivity of release. WT neurons overexpressing dmCplx
Figure 2. Effects of Overexpression of CplxI and
dmCplx in WT Hippocampal Neurons
WT neurons overexpressing CplxI or dmCplx together with
EGFP were compared to WT neurons expressing EGFP alone
(control neurons).
(A and B) Representative traces of basal evoked EPSCs (A)
and five EPSCs in response to a train of action potentials
evoked at 50 Hz (B). The arrows represent stimulations;
artifacts and action potentials are blanked.
(C) Amplitude of EPSC evoked by single action potentials.
(D) Readily releasable pool size determined by the transient
synaptic charge induced by hypertonic sucrose solution.
(E) Pvr of evoked release.
(F) Paired-pulse ratio at 20 ms interstimulus interval (ISI).
(G) The amplitudes of EPSCs evoked by a train of stimulations
at 10 Hz are normalized to the first EPSC amplitude and
plotted against stimulation number.
(H) Apparent Ca2+ sensitivity of evoked release. Normalized
EPSC amplitudes are plotted as a function of external Ca2+
concentrations ([Ca2+]e) and fitted with the standard Hill equa-
tion. EGFP, Kd = 1.30 ± 0.06 mM; CplxI, Kd = 1.20 ± 0.03 mM;
dmCplx, Kd = 2.9 ± 0.5 mM.
(I) Representative traces of mEPSCs.
(J) mEPSC frequency.
(K) mEPSC amplitude.
Data are expressed as mean ± SEM. ***p < 0.0001 compared
to control neurons. The numbers of neurons analyzed are
shown above the bars.
show a greater than 2-fold increase inKd compared
to WT neurons, indicating that overexpression of
dmCplx decreases the apparent Ca2+ sensitivity of
release (Figure 2H). Finally, we examined the spon-
taneous release and found that overexpression of
dmCplx markedly reduces the mEPSC frequency
(Figures 2I and 2J), but barely affects mEPSC ampli-
tude (Figure 2K). Overexpression of dmCplx does
not completely suppress evoked and spontaneous
release in WT neurons, presumably because the
endogenous murine Complexins compete with
dmCplx for the SNARE complex binding and still
participate in release. Altogether, these data are
consistent with the rescue experiments and show
that dmCplx mainly acts as a fusion inhibitor.
Multiple Domains of Drosophila Cplx
Are Required for Its Inhibitory Function
To elucidate the molecular mechanisms under-
lying the apparently opposite roles of murine and
Drosophila Complexins in synaptic exocytosis, we performed
a structure-function analysis of Complexins by mutagenesis
and chimeric analyses. We used Cplx-TKO neurons expressing
EGFP as controls to measure the baseline release. We then
rescued Cplx-TKO neurons with different Cplx variants (dele-
tions, point mutations, or chimeric proteins) together with
EGFP to assess whether a Cplx variant facilitates or inhibits
neurotransmitter release. We used Pvr and mEPSC frequency
as two main parameters to examine evoked and spontaneous
release efficacy, respectively. Pvr and mEPSC frequency data370 Neuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc.
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(A, D, and G) Schematic diagrams of domain organization of Cplx variants that correspond to the rescue experiments in (B), (C), (E), (F), (H), and (I). The residue
numbers shown in the domain schemes represent the amino acid numbers of the corresponding WT proteins (Figure S1). CplxI, dmCplx, and CplxIII are repre-
sented by black, red, and blue, respectively. The gray boxes indicate the central a helix, and the blue bars indicate the accessory a helix of CplxI and its homol-
ogous sequence of dmCplx. (B, C, E, F, H, and I) Summary data for Cplx-TKO neurons and Cplx-TKO neurons rescued with different Cplx variants. Data are
normalized to the mean values of the respective controls (red dashed lines and error bars). Bar graphs show normalized Pvr of evoked release (B, E, and H)
and mEPSC frequency (C, F, and I). Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.0001 compared to the corresponding controls (Cplx-
TKO). The numbers of neurons analyzed are shown on the bars.were normalized to the mean values of the corresponding Cplx-
TKO control neurons (red dashed lines and error bars in Figure 3)
to allow comparisons of different Cplx variants across different
experiments. Data from all CplxI- or dmCplx-rescued Cplx-
TKO neurons are pooled together and shown in Figure 3,
because the normalized values do not significantly differ across
experiments (p > 0.05). All of the Cplx variants studied in Figures
3 and 4 are properly expressed in neurons and targeted to the
synapses (Supplemental Results and Figure S5).
The SNARE complex binding mediated by the central a helix is
essential for CplxI to facilitate transmitter release (Xue et al.,2007), and dmCplx has also been shown to bind to the SNARE
complex (Schaub et al., 2006). Therefore, we tested whether
the SNARE complex binding is also required for dmCplx func-
tion. We confirmed that dmCplx binds to the murine SNARE
complex in a cosedimentation assay (Figure S6). We mutated
two residues, lysine 75 and tyrosine 76, to alanines, whose cor-
responding residues in CplxI are required for SNARE complex
binding (Bracher et al., 2002; Chen et al., 2002; Xue et al.,
2007). This mutant dmCplx (K75A Y76A) shows severely dimin-
ished binding to the SNARE complex (Figure S6) and fails to
block the evoked and spontaneous release in Cplx-TKO neuronsNeuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc. 371
Neuron
Complexins Balance Synaptic Vesicle FusionFigure 4. The N Termini of Both Murine CplxI and Drosophila Cplx
Facilitate Neurotransmitter Release
(A) Representative traces of evoked EPSCs. The arrows represent stimula-
tions; artifacts and action potentials are blanked.
(B) Representative traces of mEPSCs.
(C–F) Summary data for Cplx-TKO neurons and Cplx-TKO neurons rescued
with different Cplx variants. (C) Pvr of evoked release. (D) Paired-pulse ratio
at 20 ms ISI. (E) EPSC amplitude potentiation by elevation of external Ca2+
concentrations. (F) mEPSC frequency. Data are expressed as mean ± SEM.
*p < 0.05; ***p < 0.0001 compared to Cplx-TKO neurons. The numbers of
neurons analyzed are shown above the bars.372 Neuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc.(Figures 3A–3C). These data provide strong evidence that the
arrest of both evoked and spontaneous release by dmCplx
depends on its specific binding to the SNARE complex. When
we replaced the central a helix of dmCplx with that of CplxI
(denoted as dmCplx 1–53-CplxI 48–70-dmCplx 77–143), this
substitution does not affect the inhibitory function of dmCplx
(Figures 3A–3C), indicating that SNARE complex binding plays
a very similar role in dmCplx and CplxI. We therefore examined
the functional roles of the sequences that are C- and N-terminal
to the central a helix.
We first deleted the C terminus (residues 84–143) of dmCplx
(denoted as dmCplx 1–83). This mutant does not inhibit release
(Figures 3D–3F). When the C terminus of dmCplx is replaced
with that of CplxI (denoted as dmCplx 1–76-CplxI 71–134), this
chimeric protein shows impaired ability to clamp evoked and
spontaneous release, but still partially inhibits mEPSC frequency
(Figures 3D–3F). These results indicate that the C terminus of
dmCplx is important for its inhibitory function, and that the C
terminus of CplxI is only inhibitory with respect to spontaneous
release, but not as strongly as that of dmCplx.
The C terminus of dmCplx contains a farnesylation motif (the
CAAX box) that is absent from CplxI, but present in murine CplxIII
and CplxIV (Figure S1; Reim et al., 2005). Farnesylation of the
latter two proteins mediates their membrane associations, which
leads to the synaptic localization of murine CplxIII and CplxIV in
a punctate pattern. A substitution of the cysteine residue in the
CAAX box with a serine residue prevents farnesylation of CplxIII
and CplxIV, and causes them to distribute diffusely in axonal
processes and synapses, similar to CplxI (Reim et al., 2005).
To test the role of farnesylation in dmCplx function, we mutated
the cysteine residue (Cys140) in the CAAX box to a serine. Similar
to dmCplx 1–83, dmCplx C140S loses its ability to inhibit release,
indicating that farnesylation is important for the inhibitory role of
dmCplx (Figures 3D–3F). As expected, both dmCplx 1–83 and
dmCplx C140S show a diffuse subcellular distribution in axonal
processes and synapses (Supplemental Results and Figure S5).
However, farnesylation is not sufficient to cause inhibition of
release by dmCplx because replacement of the dmCplx C
terminus with the CplxIII C terminus containing a farnesylation
motif (denoted as dmCplx 1–76-CplxIII 81–158) confers a punc-
tate synaptic localization (Figure S5), but does not inhibit release.
Instead, this chimeric protein facilitates evoked release (Figures
3D–3F). Moreover, CplxIII and CplxIV facilitate release in Cplx-
TKO neurons (Reim et al., 2005). Taken together, these results
indicate that farnesylation is a prerequisite for the inhibitory func-
tion of dmCplx, but is not the cause of inhibition. The C terminus
of dmCplx is critical for its inhibitory function, which requires
both the farnesylation motif and other sequences within residues
84–143.
To assess the role of the sequence that is N-terminal to the
central a helix, we deleted residues 1–53 that contain the N
terminus and the accessory a helix of dmCplx. This mutant
(denoted as dmCplx 54–143) can only partially inhibit evoked
release, but not spontaneous release (Figures 3G–3I). When resi-
dues 1–53 of dmCplx are replaced with their homologous
sequence from CplxI, this chimeric protein (denoted as CplxI
1–47-dmCplx 54–143) partially inhibits evoked and spontaneous
release (Figures 3G–3I). When we removed only the N terminus
Neuron
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placed it with its homologous sequence from CplxI (denoted
as CplxI 1–15-dmCplx 17–143), these two mutants are still able
to abolish both evoked and spontaneous release, similar to WT
dmCplx (Figures 3G–3I, p > 0.05 compared to dmCplx WT). Alto-
gether, these data indicate that the N terminus (residues 1–16) of
dmCplx is not required for its clamping function, whereas the
sequence within residues 17–53, including the accessory a helix,
is critical for the inhibitory function of dmCplx. It is noteworthy
that CplxI 1–47-dmCplx 54–143 inhibits release more strongly
than the deletion mutant dmCplx 54–143 (Figures 3H and 3I,
p < 0.01). Since the N termini of both CplxI and dmCplx do not
inhibit release, this result is consistent with the notion that the
accessory a helix (residues 29–47) between the N terminus
and the central a helix of CplxI inhibits release (Xue et al.,
2007). Furthermore, CplxI 1–47-dmCplx 54–143 inhibits release
less strongly than WT dmCplx (Figures 3H and 3I, p < 0.01), indi-
cating that the accessory a helix of dmCplx is more inhibitory
than that of CplxI.
In summary, our mutagenesis and chimeric analyses indicate
that the inhibitory function of dmCplx in Cplx-TKO neurons
depends on its binding to the SNARE complex, and requires
the C terminus and the accessory a helix, but not the N terminus.
Note that the effects of some Cplx variants on evoked release
and spontaneous release are quantitatively different, but the
changes are qualitatively similar and are in the same direction
compared to that of the controls (Figure 3).
The N Terminus of Drosophila Cplx Facilitates
Neurotransmitter Release
We previously showed that the N terminus of CplxI is essential to
facilitate Ca2+-triggered neurotransmitter release (Xue et al.,
2007). The sequence homology between dmCplx and CplxI is
relatively high in this region (Figure S1), suggesting that their
functions may be similar. We suspected that the N terminus of
dmCplx may also facilitate release, but when present in the
context of the full-length dmCplx, the facilitatory function of
this region is masked by the overwhelming inhibitory function
of the rest of the protein. To test this hypothesis, we investigated
whether the N terminus of dmCplx can functionally substitute
that of CplxI in the rescue experiments with Cplx-TKO neurons.
Consistent with previous findings (Xue et al., 2007), deletion of
the N terminus (residues 1–15) of CplxI (denoted as CplxI 16–
134) results in a strong reduction in evoked release efficacy
compared to WT CplxI (Figure 4). Cplx-TKO neurons rescued
with CplxI 16–134 show similar Pvr of evoked release (Figures
4A and 4C) and paired-pulse ratio (Figure 4D) to Cplx-TKO
neurons (p > 0.3 for both parameters). The apparent Ca2+ sensi-
tivity of release in Cplx-TKO neurons is reduced about 2-fold
compared to WT neurons (Xue et al., 2008b). Due to this right-
ward shift of the Ca2+-dose response curve, when the external
standard Ca2+ concentrations (2 mM Ca2+, 4 mM Mg2+) are
changed to high Ca2+ concentrations (12 mM Ca2+, 1 mM
Mg2+), evoked EPSC amplitudes show greater potentiation in
Cplx-TKO neurons than in WT neurons (Xue et al., 2007;
2008b). We therefore measured EPSC amplitude potentiation
upon elevation of external Ca2+ concentrations as an indication
of apparent Ca2+ sensitivity of release. Cplx-TKO neuronsrescued with CplxI 16–134 show largerpotentiation than WT CplxI
rescue, indicating a lower Ca2+ sensitivity of release (Figure 4E).
To test whether the N terminus of dmCplx can functionally
substitute the CplxI N terminus, we generated a chimeric protein,
dmCplx 1–16-CplxI 16–134, in which the N terminus of CplxI is
substituted with the homologous sequence from dmCplx.
Remarkably, dmCplx 1–16-CplxI 16–134 behaves like WT CplxI
in evoked release, as it completely restores the defects of Cplx-
TKO in Pvr, paired-pulse ratio, and Ca
2+ sensitivity (Figures 4A,
4C, 4D, and 4E, p > 0.6 for all parameters compared to WT
CplxI), indicating that the N termini of both CplxI and dmCplx
promote evoked release.
We further examined the effect of the N terminus on sponta-
neous release. Loss of the first 15 residues in CplxI (CplxI 16–
134) strongly suppresses mEPSC frequency to about 17% of
Cplx-TKO neurons (Figures 4B and 4F). Together with the finding
that CplxI 1–47-dmCplx 54–143 inhibits release more strongly
than dmCplx 54–143 (Figures 3H and 3I), this result indicates
that the N terminus of CplxI promotes, whereas the accessory
a helix inhibits, spontaneous release. This result also implies
that the reduced spontaneous release in Cplx-TKO neurons
results from the compound effect of losing both facilitatory (the
N terminus) and inhibitory (the accessory a helix) mechanisms
associated with distinct domains of Complexins. CplxI 16–134
lacks the facilitatory N terminus but contains the inhibitory
accessory a helix; hence, the reduction of spontaneous release
in CplxI 16–134-rescued Cplx-TKO neurons is stronger than in
Cplx-TKO neurons.
We then rescued Cplx-TKO neurons with dmCplx 1–16-CplxI
16–134. This chimeric protein not only rescues the reduced
mEPSC frequency of Cplx-TKO neurons, but also enhances
spontaneous release compared to WT CplxI (Figures 4B and
4F, p < 0.001). Collectively, these data indicate that despite the
overall dominant inhibitory function of dmCplx, the N terminus
of dmCplx facilitates both evoked and spontaneous release,
similar to or better than that of CplxI. The facilitatory function
of the dmCplx N terminus is masked by the inhibitory function
of other domains in full-length dmCplx, resulting in a seeming
lack of facilitatory effect of dmCplx inCplx-TKO neurons (Figures
1, S3, and S4).
Rescue of Drosophila Cplx Null Mutants
with Murine and Drosophila Cplx
The rescue experiments in Cplx-TKO mouse neurons show that
both murine and Drosophila Complexins facilitate and inhibit
neurotransmitter release via distinct domains, but with varying
strengths (Figures 3 and 4). To compare murine and Drosophila
Complexins in fly synapses, we generated transgenic flies
carrying UAS-dmCplx, UAS-CplxI, or UAS-CplxIII, and used
the GAL4-UAS system (Brand and Perrimon, 1993) to express
them in flies (Figure S7). We chose CplxI and CplxIII because
they are the representative paralogs of two subfamilies of murine
Complexins (Reim et al., 2005). TheDrosophila Cplx null mutants
(dmCplxSH1) are semilethal (Huntwork and Littleton, 2007), and
the escaper adults are sterile and usually die within 2 weeks of
eclosion (Figure S8). Panneuronal expression of UAS-dmCplx,
UAS-CplxI, or UAS-CplxIII with the neuronal driver C155-GAL4
(Lin and Goodman, 1994) rescues the lethality and sterility ofNeuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc. 373
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that murine and Drosophila Complexins can substitute for each
other in vivo. Immunostainings show that CplxI and CplxIII are
properly targeted to the presynaptic boutons of third-instar larval
neuromuscular junctions (Figure S9).
We recorded evoked and miniature excitatory junction poten-
tials (EJPs) of neuromuscular junctions to define the properties of
evoked and spontaneous neurotransmitter release, respectively,
in these animals (Figure 5). Muscle resting membrane potentials
and input resistances are not significantly different among all
groups (Table S1A available online, p > 0.05 for both parame-
ters). dmCplx null mutants show reduced evoked release and
very high levels of spontaneous release (Huntwork and Littleton,
2007), both of which are completely rescued by neuronal expres-
sion of dmCplx (Figures 5A–5D). Remarkably, neuronal expres-
sion of CplxI or CplxIII not only rescues the decreased evoked
release in null mutants, but the evoked EJPs are significantly
larger than that of control flies or dmCplx-rescued null mutants
(Figures 5A and 5C; p < 0.001 for both CplxI rescue and CplxIII
rescue compared to control or dmCplx rescue). In contrast,
dmCplx null mutants rescued by CplxI or CplxIII still show
increased mEJP frequency compared to control flies or
dmCplx-rescued null mutants (Figures 5B and 5D; p < 0.001
for both CplxI rescue and CplxIII rescue compared to control
or dmCplx rescue). However, both CplxI and CplxIII are able to
partially suppress the increased mEJP frequency in dmCplx
null mutants (Figure 5D; p < 0.001 for both CplxI rescue and
CplxIII rescue compared to null). In fact, this partial suppression
by CplxI or CplxIII is underestimated because the quantification
of mEJP frequency in null mutants is an underestimate itself, and
is due to the numerous overlaps of mEJPs (Supplemental
Results and Figure S10). These data show that at fly neuromus-
cular junctions, murine Cplx and dmCplx play both facilitatory
and inhibitory roles in release, but murine Cplx facilitates Ca2+-
triggered release more effectively than dmCplx, whereas
dmCplx inhibits spontaneous vesicle fusion much more effi-
ciently than murine Cplx.
Overexpression of Murine and Drosophila
Cplx in WT Flies
We examined the effects of overexpression of murine and
Drosophila Complexins on neurotransmitter release at WT third-
instar larval neuromuscular junctions. We used two different
neuronal driver lines, C155-GAL4 and nSyb-GAL4 (see Experi-
mental Procedures), and the results are similar (Figure 6). Muscle
resting membrane potentials and input resistances are not
significantly different among all groups (Tables S1B and S1C,
p > 0.05 for both parameters). Compared to control, overexpres-
sion of dmCplx decreases mEJP frequency (Figures 6A, 6C, and
6G) without affecting mEJP amplitude (Figures 6A, 6D, and 6H),
but has no effect on evoked release (Figures 6B, 6E, 6F, 6I, and
6J). Together with the loss-of-function phenotypes, these results
indicate that dmCplx has stronger effects on spontaneous
release than evoked release at larval neuromuscular junctions.
In contrast, overexpression of CplxI or CplxIII markedly in-
creases mEJP frequency (Figures 6A, 6C, and 6G), evoked
EJP amplitude (Figures 6B, 6E, and 6I), and the quantal content
of evoked release (Figures 6F and 6J). It is likely that CplxI and374 Neuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc.Figure 5. Rescue of Drosophila Complexin Null Mutants with Murine
Cplx and dmCplx
(A) Representative traces of evoked EJPs. The arrows represent stimulations.
(B) Representative traces of mEJPs.
(C and D) Summary data for amplitude of EJP evoked by single action potentials
(C) and mEJP frequency (D). (#), note that the mEJP frequency of null is underes-
timated due to the overlap of individual mEJPs. Simulation indicates that the true
frequency is probably higher than 50 Hz (Supplemental Results and Fig-
ure S10). Genotypes: control (C155-GAL4/Y), null (C155-GAL4/Y; dmCplxSH1/
dmCplxSH1), dmCplx rescue (C155-GAL4/Y; UAS-dmCplx/+; dmCplxSH1/
dmCplxSH1), CplxI rescue (C155-GAL4/Y;UAS-CplxI/+; dmCplxSH1/dmCplxSH1),
and CplxIII rescue (C155-GAL4/Y; UAS-CplxIII/+; dmCplxSH1/dmCplxSH1). For
transgenic rescue experiments, multiple lines show similar results and data are
pooled together. Data are expressed as mean ± SEM. **p < 0.001; ***p <
0.0001 compared to control. The numbers of neuromuscular junctions analyzed
are shown above the bars.
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(A–F)C155-GAL4-driven overexpression of dmCplx, CplxI, and CplxIII. (A) Representative traces of mEJPs. (B) Representative traces of evoked EJPs. The arrows
represent stimulations. (C–F) Summary data of mEJP frequency (C), mEJP amplitude (D), amplitude of EJP evoked by single action potentials (E), and the quantal
content of evoked release (F). Genotypes: control (C155-GAL4/Y), C155 > dmCplx (C155-GAL4/Y; UAS-dmCplx/+), C155 > CplxI (C155-GAL4/Y; UAS-CplxI/+),
and C155 > CplxIII (C155-GAL4/Y; UAS-CplxIII/+).
(G–J) nSyb-GAL4-driven overexpression of dmCplx, CplxI, and CplxIII. Bar graphs show the summary data of mEJP frequency (G), mEJP amplitude (H), ampli-
tude of EJP evoked by single action potential (I), and the quantal content of evoked release (J). Genotypes: control (yw/Y; nSyb-GAL4/+), nSyb > dmCplx (yw/Y;
UAS-dmCplx/+; nSyb-GAL4/+), nSyb > CplxI (yw/Y; UAS-CplxI/+; nSyb-GAL4/+), and nSyb > CplxIII (yw/Y; UAS-CplxIII/+; nSyb-GAL4/+). Multiple transgenic
lines show similar results and data are pooled together. Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.0001 compared to control. The numbers
of neuromuscular junctions analyzed are shown above the bars.CplxIII compete with the endogenous dmCplx in WT flies for
binding to the SNARE complex, because both murine and
Drosophila Complexins bind to the SNARE complex (McMahon
et al., 1995; Schaub et al., 2006). This competition leads to
a partial replacement of dmCplx by CplxI or CplxIII, thus causingan enhancement of evoked release and a partial loss of inhibition
by dmCplx on spontaneous release. Taken together, these data
are in line with the rescue experiment results (Figure 5) and
support the notion that both murine and Drosophila Complexins
facilitate and inhibit release, but with varying strengths.Neuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc. 375
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Synaptic exocytosis is exquisitely controlled by a set of facilitatory
and inhibitory mechanisms, some of which are often executed by
the very same protein (Rizo and Rosenmund, 2008). As a key
regulator of the release machinery, Complexins play both facilita-
tory and inhibitory roles in vesicle fusion through distinct mecha-
nisms (Xue et al., 2007; Yoon et al., 2008). However, the remark-
able phenotypic difference between mouse and fly Complexin
null animals remained unexplained. In the present work, we
compared the functions of murine and Drosophila Complexins
in cross-species rescue experiments. Our data establish that
murine and Drosophila Complexins share a set of conserved
mechanisms in synaptic vesicle fusion.
First, the SNARE complex binding mediated by the central
a helix (residues 48–70 for CplxI and 54–76 for dmCplx) is essen-
tial for Complexin function. Mutations that diminish the interac-
tion between the central a helix and the SNARE complex abolish
the functions of both CplxI (Xue et al., 2007) and dmCplx (Figures
3B, 3C, and S6), indicating that the actions of other domains all
depend on this high-affinity interaction. The binding of the central
a helix not only can stabilize the assembled SNARE complex
(Chen et al., 2002), but perhaps more importantly, can strategi-
cally position the accessory a helix and the N terminus for their
actions (Xue et al., 2007).
Second, the accessory a helix (approximately residues 29–47
for CplxI and 33–53 for dmCplx) located between the N terminus
and the central a helix inhibits vesicle fusion (Figures 3H and 3I).
It was proposed that the inhibitory action of the accessory a helix
might arise from its interference with the binding of Synaptobre-
vin-2 to Syntaxin-1 and SNAP-25 heterodimer, which would
consequently prevent the complete zippering of the SNARE
complex (Xue et al., 2007). This model has recently been sup-
ported by the findings that Complexins can bind to Syntaxin-1
and SNAP-25 heterodimer in vitro (Guan et al., 2008; Weninger
et al., 2008; Yoon et al., 2008) and may form an alternative
four-helix bundle with target-SNAREs to inhibit fusion in a recon-
stituted fusion system (Giraudo et al., 2009).
Third, the N termini (residues 1–16) of both CplxI and dmCplx
promote release (Figure 4). It has been speculated that the CplxI
N terminus may interact with lipid membranes (Maximov et al.,
2009; Xue et al., 2007), but so far, there are no supporting
Figure 7. Distinct Functional Domains of
CplxI and dmCplx
Domains are indicated above the schematic
diagrams and the corresponding functions are
indicated below for CplxI and dmCplx. The integra-
tion of facilitatory and inhibitory functions associ-
ated with distinct domains leads to apparently
differential effects on neurotransmitter release by
CplxI and dmCplx.
biochemical data. Instead, this facilitatory
effect is likely mediated by a direct inter-
action of the Complexin N terminus with
the SNARE complex C terminus. Muta-
tions of methionine 5 and lysine 6 of CplxI
disrupt the binding of the CplxI N terminus to the SNARE
complex C terminus and abolish the facilitatory activity of the
N terminus (M.X., T.K. Craig, J. Xu, H.T. Chao, J. Rizo, and
C.R., unpublished data). Interestingly, methionine 5 is not
conserved in dmCplx and an alanine residue is at position 6 (cor-
responding to residue 5 of CplxI). It is possible that a methionine
is not absolutely required for dmCplx and other residues may
compensate for the interaction with the SNARE complex C
terminus.
Furthermore, at fly neuromuscular junctions, both murine and
Drosophila Complexins promote Ca2+-triggered release and
suppress spontaneous release, but to very different degrees
(Figures 5 and 6). Neuronal expression of murine or Drosophila
Complexins rescues the lethality and sterility of Complexin null
mutant flies, showing again that murine and Drosophila Com-
plexins share conserved functions (Figure S8).
Therefore, our cross-species rescue experiments show that
murine and Drosophila Complexins have both facilitatory and
inhibitory functions associated with similar protein domains in
synaptic vesicle exocytosis. We propose that the Complexin
central a helix binds to the middle portion of the SNARE
complex, stabilizing the SNARE complex and positioning the
accessory a helix and the N terminus (Chen et al., 2002; Xue
et al., 2007). The accessory a helix replaces the C terminus of
the Synaptobrevin-2 SNARE motif in the four-helix bundle, pre-
venting the full assembly of the SNARE complex to suppress
fusion (Giraudo et al., 2009; Xue et al., 2007). The N terminus
directly interacts with the C-terminal portion of the SNARE
complex, likely stabilizing this unstable region of the SNARE
complex to promote membrane fusion. However, the relative
strengths of these functions are remarkably different between
murine and Drosophila Complexins. We propose that the inte-
gration of facilitation and inhibition, which are associated with
distinct domains, determines the overall effect of murine and
Drosophila Complexins on neurotransmitter release in a given
synapse (Figure 7). The overall action of murine and Drosophila
Complexins is unlikely to be a linearly additive effect of all facili-
tatory and inhibitory actions. However, it is clear that the facilita-
tory function is preponderant in murine Complexins, whereas the
inhibitory functions of the accessory a helix and the C terminus
predominate in Drosophila Complexin. Thus, a relative shift in
the balance of facilitatory and inhibitory functions results in376 Neuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc.
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transmitter release, and leads to apparently very different loss-
of-function phenotypes in flies and mice. Our results emphasize
the functional similarities and differences between murine and
Drosophila Complexins, and reconcile previous contradictory
hypotheses of Complexin in vivo function (Cai et al., 2008; Hunt-
work and Littleton, 2007; Reim et al., 2001; Xue et al., 2008b).
Moreover, our data illustrate the complexity of Complexin func-
tion and strongly support the notion that Complexins play dual
roles in vesicle fusion (Xue et al., 2007).
Our model is clearly different from the previous models of
Complexins based on the fusion clamp hypothesis (Giraudo
et al., 2006; Maximov et al., 2009; Schaub et al., 2006; Tang
et al., 2006). These models propose that Complexins arrest
primed synaptic vesicles at a hemifused and metastable state,
which provides the substrate for Ca2+-bound Synaptotagmin-1
to release the clamping function of Complexins, allowing the
fast and synchronous fusion. The lack of Complexins and there-
fore the lack of metastable vesicles for Synaptotagmin-1 action
causes excessive spontaneous release and deficient Ca2+-
triggered fast release. However, our in vivo results speak against
this model because murine Complexins do not completely clamp
the excessive spontaneous release in Drosophila Complexin null
mutants, yet they actually enhance Ca2+-evoked fast release
even better than Drosophila Complexin (Figure 5). This observa-
tion indicates that the decreased Ca2+-evoked fast release in
Drosophila Complexin null mutants is not functionally coupled
to the increased spontaneous release frequency. Could it be
that the reduced evoked release in Drosophila Complexin null
mutants is due to a partial depletion of readily releasable vesicles
by the high-frequency spontaneous release? This is unlikely
because the vesicle recruitment rate is usually at least 100-fold
higher than the spontaneous release rate at resting intracellular
Ca2+ level (Neher and Sakaba, 2008), and therefore a 20- to
30-fold increase in spontaneous release rate should not signifi-
cantly change the vesicle pool size in Drosophila Complexin
null mutants. In addition, murine-Complexin-rescued Drosophila
Complexin null synapses still exhibit strongly increased sponta-
neous release, yet the evoked release is even larger than that of
WT synapses, arguing that high-frequency spontaneous release
in null mutants is unlikely to exhaust vesicles, causing a
decreased evoked release.
A recent fusion clamp model proposes that Complexins
control the force transfer from the SNARE complex to the
membranes and assist the SNAREs in exerting force on the
membranes (Maximov et al., 2009). This model assumes that
Complexins are released from the SNARE complex by Synapto-
tagmin-1 and Ca2+, but it is physically unclear how Complexins
can help SNAREs exert force on the membranes if they are
dissociated upon Ca2+ influx. In contrast, our model requires
Complexins to remain bound to the SNARE complex upon
Ca2+ influx and is consistent with the notion that Complexins
could function independently from Synaptotagmin-1 (Xue
et al., 2007; Yoon et al., 2008).
Drosophila Complexin in Cplx-TKO neurons abolishes both
evoked and spontaneous release without altering the number
of fusion-competent vesicles measured by hypertonic sucrose
solution (Figure 1). This effect is intriguing, because very fewmolecular manipulations specifically block the synaptic vesicle
cycle at the final fusion step. Drosophila Complexin does not
change the number of primed vesicles, indicating that the initial
formation of the SNARE complex is not affected by Drosophila
Complexin. The inhibitory effect of Drosophila Complexin
requires its binding to the SNARE complex (Figures 3B, 3C, and
S6). Hence, we hypothesize that when theDrosophilaComplexin
central a helix binds to the partially assembled SNARE complex,
the accessory a helix together with the C terminus prevents the
further assembly of the SNARE complex C terminus, thereby
arresting vesicles at the primed state. It is currently unknown
how, mechanistically, the C terminus of Drosophila Complexin
inhibits release. One possibility is that the C terminus may fold
back toward the N-terminal direction and cooperate with the
accessory a helix to inhibit vesicle fusion.
The phenotypic differences between fly and mouse knockouts
seem dramatic, but it is worth noting that an increase of just 1.4
kcal/mol in the strength of a protein-protein interaction, which
can arise simply from the formation of one hydrogen bond or
salt bridge, leads to a 10-fold increase in affinity according to
the Boltzmann equation. Hence, subtle changes in the molecular
interactions of murine and Drosophila Complexins can suffice to
tip the balance between facilitatory and inhibitory strengths. For
example, protein sequence alignments show that the lengths
and the amino acid compositions of the accessory a helices
differ among different Complexins (Figure S1; Huntwork and Lit-
tleton, 2007; Reim et al., 2005), which may cause different inter-
actions of the accessory a helix with Syntaxin-1 and SNAP-25
heterodimer, thus changing its inhibitory strength.
The effects of murine Complexins in murine and fly synapses
are not identical, as murine Complexins promote evoked release
and inhibit spontaneous release in fly neuromuscular junctions
(Figure 5), and promotes both types of release in mouse central
synapses (Figure 1; Strenzke et al., 2009; Xue et al., 2008b). Like-
wise, the effects of Drosophila Complexin in murine and fly
synapses are not identical either, as it strongly inhibits sponta-
neous release and mildly promotes evoked release in fly neuro-
muscular junctions (Figure 5), and strongly inhibits both types of
release in mouse synapses (Figures 1, S3, and S4). These obser-
vations indicate that in addition to the Complexin-intrinsic prop-
erties, the molecular differences between species or synapses
could differentially affect the facilitatory and inhibitory functions
of murine and Drosophila Complexins, thereby tilting the facilita-
tion and inhibition balance and contributing to the phenotypic
differences.
Complexins represent a family of proteins that maintain
a highly conserved core of sequences and at the same time
display great diversity across paralogs and orthologs (Huntwork
and Littleton, 2007; Reim et al., 2005). This is likely reflected in
their functions, namely conserved facilitatory and inhibitory
mechanisms with varying strengths in neurotransmitter release.
It will be interesting to test Complexin function in some other
model organisms along the phylogenetic tree, such as worm
and fish, to determine if and how the balance between facilitatory
and inhibitory functions of Complexins has changed during
evolution. At different synapses, the strengths of facilitation
and inhibition of Complexins may be differentially regulated in
a paralog- and ortholog-dependent fashion, thereby regulatingNeuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc. 377
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diversity and specificity. Furthermore, the ability of Drosophila
Complexin to inhibit neurotransmitter release in mammalian
neurons potentially provides a powerful tool to manipulate
synaptic function to study neural circuits, as one should be able
to express Drosophila Complexin to inhibit or even abolish
synaptic transmission in a spatially and temporally specific
manner.
EXPERIMENTAL PROCEDURES
Lentivirus Constructs and Production
A modified lentiviral vector (Lois et al., 2002; Xue et al., 2008a) was used, in
which a human Synapsin-1 promoter and a ubiquitin C promoter drive the
expression of Cplx variants and the reporter, EGFP, respectively. The same
vector without Cplx served as a control construct. For EGFP-tagged fusion
proteins, the ubiquitin C promoter and EGFP reporter were removed from
the vector. WT rat CplxI (GenBank accession number: NM_022864), mouse
CplxIII (AY264290), and Drosophila Cplx (AY121629) cDNAs were used to
generate all Cplx variants by standard recombinant DNA techniques, and
the cDNAs were subsequently cloned into the lentiviral vector. The resulting
constructs were used for the production of both lentiviruses and the transfec-
tion of hippocampal neurons. Myc-tagged Cplx variants were generated by
fusing a linker (SGGSGGTGG) followed by a c-Myc (EQKLISEEDL) to the C
terminus of Cplx variants. EGFP-tagged Cplx variants were generated by
fusing EGFP to the N terminus of Cplx variants.
Lentiviruses were produced by cotransfecting HEK293T cells with the lenti-
viral vector and two helper vectors, pVSVg and pCMV-delta R8.9 (Lois et al.,
2002). Viral supernatants were collected 48–72 hr after transfection, and virus
particles were concentrated using a centrifugal filter device (Amicon Ultra-15,
Millipore). Viruses were titered with WT hippocampal mass-cultured neurons.
For all the lentiviral expression experiments with cultured neurons, about 2.33
106 infectious virus units were used to infect neurons in a 35 mm diameter well
containing 2 ml culture medium within 24 hr after plating neurons.
Mice, Neuronal Cultures, and Transfection
Cplx-TKO mice were obtained by interbreeding of mice homozygous for the
CplxII and CplxIII mutations, and heterozygous for the CplxI mutation as
described (Xue et al., 2008b). All procedures to maintain and use these mice
were approved by the Institutional Animal Care and Use Committee for Baylor
College of Medicine and Affiliates.
Primary neuronal cultures were prepared as described (Xue et al., 2008b).
Briefly, hippocampal or striatal neurons were prepared from postnatal day
0 mice and plated at 300 cm2 density on WT astrocyte microislands for autap-
tic neuron electrophysiology. Hippocampal neurons were plated at 4000 cm2
density on continental WT astrocyte feeder layer for mass-cultured neuron
electrophysiology. For western blotting and immunocytochemistry of protein
expression, hippocampal neurons were plated at 10,000 cm2 and 5000 cm2
densities, respectively, on continental WT astrocyte feeder layer.
Hippocampal neurons were transfected using the calcium phosphate
method as described (Xia et al., 1996) with modification. Briefly, at day
in vitro (DIV) 3 or 4, the conditioned neuronal culture medium was removed
and saved. Neurons were washed two times with Neurobasal-A medium
and incubated in Neurobasal-A medium at 5% CO2 incubator for at least
1 hr. Two micrograms of DNA was used to prepare calcium phosphate/DNA
precipitates for each well (12-well plate). Neurons were incubated with calcium
phosphate/DNA precipitates for 10–12 min and subsequently washed two
times with astrocyte culture medium (DMEM medium supplemented with
10% fetal calf serum). Neurons were then incubated in astrocyte culture
medium for 1–2 hr before they were moved back to the conditioned neuronal
culture medium.
Drosophila Transgenesis and Strains
WT rat CplxI, mouse CplxIII, and Drosophila Cplx cDNAs were cloned into the
pUAST vector (Brand and Perrimon, 1993) and injected into the yw; Ki,378 Neuron 64, 367–380, November 12, 2009 ª2009 Elsevier Inc.P{D2-3}/+ embryos by standard procedures (Rubin and Spradling, 1982) to
obtain transgenic lines. C155-GAL4 (Lin and Goodman, 1994) was obtained
from the Bloomington Stock Center, nSyb-GAL4 (neuronal Synaptobrevin-
GAL4) from Barry Dickson (Research Institute of Molecular Pathology, Austria),
and dmCplx null mutant (dmCplxSH1; Huntwork and Littleton, 2007) from
J. Troy Littleton (Massachusetts Institute of Technology, USA). Flies were
maintained at 25C for all experiments. For lifespan tests, adult flies were
transferred to fresh food vials every 2 days, and were counted every day.
Western Blotting, Immunocytochemistry, and Cosedimentation
Assays
To examine Cplx expressions, proteins were extracted from cultured neurons
or fly heads and analyzed by western blotting. Presynaptic localization of Cplx
variants was examined using immunocytochemistry and confocal micros-
copy. Cosedimentation assays were performed to examine the SNARE
complex binding of dmCplx using recombinant glutathione S-transferase
(GST)-dmCplx fusion proteins that were generated in HEK293FT cells. These
procedures are described in detail in Supplemental Experimental Procedures.
Electrophysiology of Cultured Neurons
Whole-cell voltage-clamp experiments were performed on approximately
equal numbers of neurons from every group in parallel on the same day
in vitro (DIV 9–14) at room temperature (23C –24C). Neurons were clamped
at 70 mV with an Axopatch 200B amplifier (Molecular Devices) under the
control of Clampex 10.0 (Molecular Devices). Data were acquired at 10 kHz
and low-pass filtered at 5 kHz. The series resistance was compensated about
80% and only cells with series resistances below 10 MU were analyzed. The
standard extracellular solution contained (in mM) NaCl, 140; KCl, 2.4; HEPES,
10; glucose, 10; CaCl2, 2; and MgCl2, 4 (300 mOsm; pH 7.4). For Ca
2+ sensi-
tivity experiments, the Mg2+ concentration was kept at 1 mM and Ca2+
concentration varied as indicated in extracellular solutions. Hypertonic solu-
tion for measuring RRP size was made by adding 500 mM sucrose to the stan-
dard extracellular solution. For hippocampal glutamatergic autaptic neurons,
the patch pipette solution contained (in mM) K-Gluconate, 146; HEPES,
17.8; EGTA, 1; MgCl2, 0.6; ATP-Mg, 4; GTP-Na, 0.3; Phosphocreatine, 12;
and Phosphocreatine kinase, 50U ml1 (300 mOsm; pH 7.4). For striatal
GABAergic autaptic neurons and hippocampal mass-cultured neurons, the
patch pipette solution contained (in mM) KCl, 136; HEPES, 17.8; EGTA, 1;
MgCl2, 0.6; ATP-Mg, 4; GTP-Na, 0.3; Phosphocreatine, 12; and Phosphocre-
atine kinase, 50U ml1 (300 mOsm; pH 7.4).
For hippocampal and striatal autaptic neurons, action-potential-evoked
EPSCs or IPSCs were triggered by a 2 ms somatic depolarization to 0 mV.
Neurons were stimulated at 0.2 Hz (for EPSCs) or 0.1 Hz (for IPSCs) in standard
extracellular solution to measure basal evoked synaptic responses. RRP size
was determined by measuring the charge transfer of the transient synaptic
current induced by a pulsed 8 s long application of hypertonic sucrose solution
directly onto the neuron. RRP vesicle numbers in Figure 1 were calculated by
the ratio of RRP charges and mEPSC charges. To obtain Pvr, the evoked
response and the response to the hypertonic sucrose solution were recorded
successively from the same neuron. Evoked response was integrated for 1 s
(for EPSC) or 2 s (for IPSC) to calculate the charge transfer. Pvr was calculated
by the ratio of evoked response charge and RRP size. Short-term plasticity
was examined by evoking synaptic responses at 50 or 10 Hz in standard
external solution. Paired-pulse ratio was measured by dividing the second
EPSC amplitude with the first EPSC amplitude. To examine the apparent
Ca2+ sensitivity of release, EPSCs were evoked at 0.2 Hz. Each test measure-
ment at different external Ca2+ concentrations was preceded and followed by
a measurement in standard extracellular solution to control for the rundown of
synaptic responses. The EPSC amplitude at each Ca2+ concentration was
normalized to the amplitude in standard extracellular solution. All data were
then normalized to the maximal value. Data were fitted with the standard Hill
equation: Y = M/(1 + (Kd / X)
n); Y, EPSC amplitudes; X, Ca2+ concentrations;
M, maximum EPSC amplitude; Kd, dissociation constant; n, Hill coefficient.
mEPSCs and mIPSCs were recorded for 1–2 min and were blocked by a gluta-
mate receptor antagonist, kynurenic acid (3 mM), or a GABAA receptor antag-
onist, gabazine (15 mM), respectively. Recordings in the presence of antago-
nists were used to subtract the false positive events.
Neuron
Complexins Balance Synaptic Vesicle FusionFor hippocampal mass-cultured neurons, mEPSCs or mIPSCs were re-
corded from randomly chosen neurons in standard external solution with
0.5 mM tetrodotoxin and 15 mM gabazine or 3 mM 2,3-Dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX), respectively. Record-
ings in the presence of antagonists were used to subtract the false positive
events.
Data were analyzed offline using AxoGraph X (AxoGraph Scientific). To
detect mEPSC and mIPSC events, traces were digitally filtered at 1 kHz offline
and events were automatically selected with a scaled-template algorithm
(Clements and Bekkers, 1997) in AxoGraph X. The template function is a
double exponential with a scalable amplitude, a rise time constant of 0.5 ms,
a decay time constant of 4 ms (for mEPSC) or 18 ms (for mIPSC), a baseline
of 5 ms, and a template length of 10 ms (for mEPSC) or 18 ms (for mIPSC).
False positive events were subtracted as described (Xue et al., 2008b). It
was not possible to perform false positive subtraction for three dmCplx-
rescued Cplx-TKO neurons in Figure 1, and therefore the nonsubtracted
values were used. Statistic significances were tested using Student’s t test,
the nonparametric Mann-Whitney test, or one-way analysis of variance.
Electrophysiology of Drosophila Larval Neuromuscular Junctions
Male third-instar larvae were dissected and bathed in HL-3 solution containing
(in mM) NaCl, 70; KCl, 5; NaHCO3, 10; HEPES, 5; sucrose, 11.5; trehalose, 5;
MgCl2, 20, and CaCl2, 0.7 (for Figure 5) or 0.6 (for Figure 6) (pH 7.4). Body wall
muscle 6 (segment A3 or A4) was used for intracellular recordings with sharp
electrodes filled with 2 M KAc and 1 M KCl (about 80–100 MU resistance).
Current-clamp recordings were performed using an Axoclamp 2B amplifier
in bridge mode under the control of AxoGraph X or Clampex 8.2. Data were
acquired at 10 kHz and low-pass filtered at 3 kHz. Only the muscles with
resting membrane potential below60 mV were used for experiments. Muscle
input resistances were determined by a current injection of 1 nA. Miniature
EJPs were recorded for 1–2 min. Evoked EJPs were elicited by pulling the
cut end of the innervating segmental nerve into a suction electrode and
passing a 0.5–0.8 ms depolarizing pulse with a DS2A-Mk. II constant voltage
isolated stimulator (Digitimer) to activate both motoneurons. Ten to thirty
evoked EJPs were recorded for each muscle. All experiments were performed
at room temperature (20C–22C).
Data were analyzed offline using AxoGraph X. To detect mEJPs, traces were
digitally filtered at 1 kHz offline and events were automatically selected with
a scaled-template algorithm (Clements and Bekkers, 1997) in AxoGraph X.
The template function is a double exponential with a scalable amplitude,
a rise time constant of 5 ms, a decay time constant of 25 ms, a baseline of
2 ms, and a template length of 30 ms. Template length was reduced to
12 ms for Drosophila Complexin null mutants to better detect the high-
frequency events (for Figure 5). The quantal content of evoked release was
calculated by the ratio of evoked EJP amplitude and mEJP amplitude. Evoked
EJP amplitude was not corrected for nonlinear summation. For Drosophila
Complexin null mutants and null mutants rescued by CplxI or CplxIII, high-
frequency mEJPs are severely overlapped, which precludes the proper
measurement of mEJP amplitude and consequently the calculation of the
quantal content of evoked release. Statistic significances were tested using
one-way analysis of variance.
SUPPLEMENTAL DATA
Supplemental data for this article include ten figures, one table, Supplemental
Results, and Supplemental Experimental Procedures and can be found at
http://www.cell.com/neuron/supplemental/S0896-6273(09)00754-5.
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